Advanced Blockchain AG

  • WKN: A0M93V
  • ISIN: DE000A0M93V6
  • Land: Deutschland

Nachricht vom 09.11.2021 | 13:39

Advanced Blockchain AG's portfolio company is launching it's peaq token

DGAP-News: Advanced Blockchain AG / Key word(s): Cryptocurrency / Blockchain/Miscellaneous
09.11.2021 / 13:39
The issuer is solely responsible for the content of this announcement.

Advanced Blockchain AG's (Frankfurt, Primary Market Düsseldorf, XETRA: ISIN DE000A0M93V6) spun-out portfolio company peaq Technology GmbH announced plans to launch their native PEAQ token (https://www.peaq.network/) in early 2022. A private token sale, supported by Advanced Blockchain, is currently ongoing.

 

The peaq-project was founded in 2017 and got subsequently spun out of Advanced Blockchain in 2020. The focus of peaq is the optimization of various processes in different industries with custom implementations of Distributed Ledger Technology (DLT). peaq's products have already found many use cases, for example in eMobility and other aspects of the automotive industry.

 

The peaq network will now be launched as its own platform and is going to be anchored to the  Polkadot network (https://polkadot.network/). Advanced Blockchain is excited to announce that the peaq testnet was successfully deployed and first token transactions are up and running. The peaq network aims to become a key piece of the infrastructure of the Economy of Things (Machine Economy). peaq's vision is to transform the Web2-based Internet of Things into the Web3-based Economy of Things. 

 

Advanced Blockchain together with peaq look forward to the long-awaited peaq platform and token launch, and the many functionalities and opportunities it will unlock for the portfolio company. The token generation event (TGE) is scheduled for early 2022.

 

Further information about Advanced Blockchain AG and peaq can be found at their respective websites, https://www.advancedblockchain.com/ and https://www.peaq.io/



09.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021